# Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

> **NCT04039867** · PHASE2 · TERMINATED · sponsor: **University of California, Irvine** · enrollment: 17 (actual)

## Conditions studied

- Carcinoma, Transitional Cell

## Interventions

- **DRUG:** Oxaliplatin with Gemcitabine

## Key facts

- **NCT ID:** NCT04039867
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01-20
- **Primary completion:** 2011-10-06
- **Final completion:** 2011-10-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Trial was terminated due to halt in funding.
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04039867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04039867, "Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04039867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*